- Reaction score
- 5
Saw this on tressless, don’t know if it was posted here. Says phase 2 results June 2022.
Yes we were and are eagerly waiting for June, thanks for that document anyway.Saw this on tressless, don’t know if it was posted here. Says phase 2 results June 2022.
Yes we were and are eagerly waiting for June, thanks for that document anyway.
Hope that the leaked results aren't bullshit haha !! Gonna be a fun wait ! Last time I was excited for results was for... Brotzu and their conference lmao
"Diameter doesn't change"![]()
I think you got the wrong price. Where do you see 280USD for 5g?Not sure if I'm allowed to say company names? But I might give it a go.seems expensive but $279 = £205 for 5000mg at 10mg a day is less than a pound a day, that's less than minoxadil.
I'm not American but they seem to be recruiting for trials
ClinicalTrials.gov
clinicaltrials.gov
Edit: actually I have a couple questions:
Is selleckchem legit?
What vehicle should I use, currently I use zix so can I just use alcohol/distilled water?
How is this stored in the freezer like RU?
Allegedly, TAHC (Target area hair count) of pyrilutamide from the phase II study was 22.5/cm2 according to people who saw the leak. If true, and again that is a big if, these results are very encouraging.
Fair point. We'll see...
I still think people shouldnt expect much regrowth from the antiandrogenic angle. Even shutting down the T/DHT pathway almost completely (castration) didnt regrow significant amount of hair on its own.
If it can achieve long-term maintenance even with some minimal regrowth or thickening it's already a win in my book. I'm not in the pursuit of a juvenile NW1 hairline and I don't harbor any grand delusions, I'm quite happy to live with my NW3 hairline as long as it doesn't get any worse and becomes slightly more revitalized than it is right now.
just a friendly reminder that 6 months result of breezily was 21/cm^2 in TAHC. then after 12 months it went totally to sh*t. Kintor does not plan to do a 12 month phase 3 trial. they are both topical anti androgens and have a very comparable mechanism of action. so even if the leaked results were to be accurate and the side effect profile was to be favorable, who says that pyralutamide shares not the same property that it cannot maintain the regrowth for more than half a year. and we would never know because they do not have to do a 12 month trial. maybe they will have to do one for the FDA once they are in phase 3 in the US. but that will take another 1-2 years minimumAllegedly, TAHC (Target area hair count) of pyrilutamide from the phase II study was 22.5/cm2 according to people who saw the leak. If true, and again that is a big if, these results are very encouraging.
just a friendly reminder that 6 months result of breezily was 21/cm^2 in TAHC. then after 12 months it went totally to sh*t. Kintor does not plan to do a 12 month phase 3 trial. they are both topical anti androgens and have a very comparable mechanism of action. so even if the leaked results were to be accurate and the side effect profile was to be favorable, who says that pyralutamide shares not the same property that it cannot maintain the regrowth for more than half a year. and we would never know because they do not have to do a 12 month trial. maybe they will have to do one for the FDA once they are in phase 3 in the US. but that will take another 1-2 years minimum
I still do not understand why breezula did so well initially and then so poorly when other anti androgens like finasteride or dutasteride really start to show the best results after 12-15 months. its strange because anti androgens take a long time to show their positive effects however with this one it seems to be potent initially and then diminish(breezula). personally I am hopeful that Pyrilutamide does not have this property
Nahh the AR degrader is GT20029 and it is years away.I was under the impression that Pyrilutamide was an androgen degrader. If so then its mode of action is far different than an anti-androgen like Breezula or RU. The safety profile would also be better.
Not to be that guy, but Breezula reported 20.7/cm2 increase at month 6 for their target dose as well. By month 12 it was 4.70/cm2 above base line, and I actually remember they did some weird reporting metric where the count was the difference from the control group, meaning that people were under baseline at 12 months on the top dose despite having an increase similar to KX at 6 months. Notice how every stack has a "significance vs baseline" star except for the 12 month?Allegedly, TAHC (Target area hair count) of pyrilutamide from the phase II study was 22.5/cm2 according to people who saw the leak. If true, and again that is a big if, these results are very encouraging.
One difference though is that Pyrilutamide has a way higher binding affinity than breezula (breezula is super weak, like 30 times weaker than testosterone). So hopefully pyrilutamide can hold its results for longer.just a friendly reminder that 6 months result of breezily was 21/cm^2 in TAHC. then after 12 months it went totally to sh*t. Kintor does not plan to do a 12 month phase 3 trial. they are both topical anti androgens and have a very comparable mechanism of action. so even if the leaked results were to be accurate and the side effect profile was to be favorable, who says that pyralutamide shares not the same property that it cannot maintain the regrowth for more than half a year. and we would never know because they do not have to do a 12 month trial. maybe they will have to do one for the FDA once they are in phase 3 in the US. but that will take another 1-2 years minimum
I still do not understand why breezula did so well initially and then so poorly when other anti androgens like finasteride or dutasteride really start to show the best results after 12-15 months. its strange because anti androgens take a long time to show their positive effects however with this one it seems to be potent initially and then diminish(breezula). personally I am hopeful that Pyrilutamide does not have this property
Theoretically, can it show long term results (10+ yrs) like finasteride?One difference though is that Pyrilutamide has a way higher binding affinity than breezula (breezula is super weak, like 30 times weaker than testosterone). So hopefully pyrilutamide can hold its results for longer.
Yes, that's why Breezula is dosed at 7.5% to compensate for it's weakness. Pyrilutamide can't be dosed higher because it goes systemic at even 1.5x the tested dose (12mg), so what you see is what you will get.One difference though is that Pyrilutamide has a way higher binding affinity than breezula (breezula is super weak, like 30 times weaker than testosterone). So hopefully pyrilutamide can hold its results for longer.
